Traditional qualitative gel electrophoresis approaches lack accurate and quantitative assessment of mixed chimerism in BMT patients. The likelihood of informative markers is greatly increased using simultaneous amplification of 10 highly polymorphic loci with fluorescent-labeled primers in an automated DNA sequencer. This allows for more precise interpretation of mixed chimerism with a detection level approximating 1%. To evaluate this approach to quantitative assessment of chimeric populations we mixed varying proportions of samples from two unrelated donors, by either mixing aliquots of DNA isolated from whole blood, or by first counting the white blood cells and mixing varying proportions of cells together prior to DNA isolation. The allelic-peak area ratios were identical to allelic-peak height ratios and corresponded to the proportion of mixed DNA, regardless of the method used to create the mixture. Formulas to provide routine, consistent and quantitative interpretation of mixed chimerism are presented. We analyzed 14 allograft recipients and one autologous BMT patient with transfusion-induced GVHD. In all cases, at least four out of nine markers were informative. Inter-laboratory concordance of results was also obtained with an eight marker panel using an automated Alf-Express. In conclusion, the automated DNA fluorescent-labeled primer approach using an eight to 10 marker panel is quantitative and informative in assessing chimerism.
replaced by more sensitive PCR-based multiplex amplification of informative tandem repeat genetic markers such as variable number tandem repeat (VNTR) or short tandem repeat (STR) loci. [5] [6] [7] STR markers are generally two to seven nucleotides in length. Since the number of repeat units at an STR locus may differ, alleles of many different lengths are possible. This variation at a particular STR locus is a useful tool for human identification. 8 In the BMT setting, testing for genetic markers has several utilities 9 including: routine post-transplant documentation of host/donor origin of WBC; 10, 11 evaluation of host/donor cell populations in patients with inadequate marrow functions; 12 to identify whether cells from a transfusion donor can be implicated in causing GVHD; 13 to define whether recurrent malignancy or EBV-lymphoproliferative syndrome has originated from host or donor cells; 14 to assess prognostic risks of rejection and recurrent malignancy; 15 in residual disease monitoring to estimate the persistence of donor cells in patients with recurrent CML; 16 to evaluate the status of rejection in second transplant candidates 17 and in patients with aplastic anemia or other disorders at increased risk of rejection. 18, 19 This approach of testing for chimerism has been used in the verification of genetic identity of twins, 20 and in the detection of maternally derived cells in patients with severe combined immunodeficiency. 21 Recently highly sensitive quantitative assessment of chimerism using automated fluorescent-labeled PCR primers 22 has obviated need for more traditional approaches of detecting STR loci using labor intensive and cumbersome radio isotopic methods.
Here we describe the assessment of clinical chimerism using simultaneous amplification of 10 highly polymorphic loci with fluorescent-labeled primers in an automated DNA sequencer.
Patients and methods

Patients
Study cases were obtained from blood and bone marrow samples submitted to the Immunopathology Laboratory, Henry Ford Hospital (Detroit, MI, USA) for routine pretransplant HLA typing and for post-transplant engraftment testing by VNTR analysis.
Sample preparation
DNA from nucleated blood and bone marrow cells was extracted using the QIAamp Blood Kit (Qiagen, Valencia, CA, USA). For simulated chimerism experiments, DNA was extracted from whole blood cells from two unrelated individuals and samples were mixed in different proportions ranging from 1% to 50% following spectrophotometric assessment of DNA concentrations. From additional blood draws, different proportions of cells were mixed, after performing cell counts. The total number of cells used for each DNA extraction was 1 million.
PCR and fluorescent marker analysis
Profiler kit (ABI, Perkin-Elmer) co-amplifies the repeat regions of nine short tandem repeat loci: D3S1358, vGA, FGA, THO1, TPOX, CSF1P0, D5S818, D13S317 and D7S820. A segment of the X-Y homologous gene amelogenin is also amplified (Table 1) . Amplifying a segment of the amelogenin gene with a single primer pair is useful for gender identification because different length products from the X and Y chromosomes are generated. The profiler kit allows multiple loci, including loci that have overlapping size ranges, to be analyzed in a single gel lane. Alleles for overlapping loci are distinguished by locus-specific primers with different color dyes. Spectral overlap between the dyes is removed by the analysis software, using dye-specific and instrument-specific matrix files. Genescan software automatically analyzes the collected data, which can then be exported into Genotyper software for automatic genotyping of alleles.
DNA samples were prepared for PCR and run on a sequencing gel according to instructions in the Profiler kit (ABI, Perkin-Elmer, Applied Biosystems, Foster City, CA, USA). The AmpFlSTR Profiler contains all the reagents necessary to amplify the nine STR loci and the amelogenin gene. One l of the PCR products was electophoresed using 7.5% Long Ranger gels (FMC Bioproducts, Philadelphia, PA, USA) prepared on 36 cm well-to-read plates on the ABI PRISM 377 DNA sequencer (Perkin Elmer, Applied Biosystems).
Gels were analyzed using GeneScan Analysis software (Perkin Elmer, Applied Biosystems). Percent engraftment using peak area and peak height was measured as fluor- 
Sensitivity
Final concentration of DNA per PCR reaction tube was 1.5-2 ng. Fluorescent-tagged STR primers can detect as little as 100 pg of target DNA. 
Example: Figure 1b, 
Example: Table 2 , marker THO1 (7, 9.3; 6, 9) (C) Recipient and donor are both heterozygous (one of the alleles is shared, and the other is informative): Ignore the shared allele (see explanation in F, below).
An example is not provided for this scenario.
(D) Recipient is heterozygous, and donor is homozygous (no shared alleles):
Example: Table 2 , marker vWA (16, 18; 17,17) (E) Recipient is homozygous, and donor is heterozygous (no shared alleles)
(F) Recipient is homozygous, and donor is heterozygous (one of the alleles is shared, and the other is informative). Example: X, X; XY.
(G) Recipient is heterozygous, and donor is homozygous (one of the alleles is shared, and the other is informative).
Example: X, Y; XX.
Accurate calculations are not possible in cases (F) and (G) because the contribution of donor and recipient to the shared peaks cannot be assessed due to the frequent unequal peak height between the alleles. (3) After performing calculations for each informative allele, calculate the average percentage. This will be the percentage of donor cells in the post-transplant sample.
Results
Mixed DNA samples
An example of the results with a 50% mixture of DNA from two unrelated individuals is shown in Figure 1 . Six out of nine markers were informative for calculation of mixed chimerism profiles. The results of the calculations using peak height or peak area are summarized in Figure  2 (panel a1 and b1). Average peak heights and areas for all six informative markers are summarized in Figure 2 (panel a2 and b2). In the range of 2.5-50% the results were concordant with the expected values, regardless of whether peak height or peak areas were used. At 1% the peaks were Results illustrating simulated chimerism experiments using DNA mixtures from two individuals. DNA was extracted from whole blood cells and quantitated using spectrophometry. Different DNA mixtures were prepared ranging from 2.5% to 50%. 1.5 ng of DNA from each mixture was used for multiplex PCR using AmpFlSTR Profiler. Six of 10 alleles were informative. Peak height (a1 and a2) and peak area (b1 and b2) of informative alleles were used to calculate percent chimerism. (a1) Graphical representation of calculated vs expected peak heights for informative alleles at different dilutions. (a2) Graphical representation of an average of all six informative markers calculated using peak heights. Even though marker vWA in Figure  a1 appears to outlie the others, when plotted as an average of all six markers, concordance between the calculated and the expected peak heights showed minimal deviation from 1 (R 2 = 0.99). (b1) Graphical representation of calculated vs expected peak areas for informative alleles at different dilutions. (b2) Graphical representation of an average of all six informative markers calculated using peak areas. Even though marker vWA in Figure a1 appears to outlie the others, when plotted as an average of all six markers, concordance between the calculated and the expected peak areas showed minimal deviation from 1 (R 2 = 0.99).
detectable, but the results were not concordant with expected values and were not reproducible (not shown).
Mixed cell samples
The experiments were repeated using DNA extracted from mixtures of mononuclear cells from the same two individuals. The results, shown in Figure 3 (panel a and b) , were comparable with the mixed samples of DNA from whole blood. Table 2 summarizes allelic information of recipient and donor (simulated experiments) including STR locus with corresponding marker size. Appropriate formulas already described in Patients and methods above are indicated in the far right column.
Allelic information of simulated experiments
Patient samples
For analysis of patient samples, allele peaks detected in the post-transplant test sample were compared with the patient pretransplant and the donor samples to determine if the Dilution Dilution Figure 3 Results illustrating simulated chimerism experiments using DNA mixtures from two individuals. Cell mixtures ranging from 2.5% to 50% were prepared from mononuclear cells isolated from two different individuals. Extracted DNA from the different mixtures was quantitated using spectrophometry. 1.5 ng of DNA from each mixture was used for multiplex PCR using AmpFlSTR Profiler. Six of 10 alleles were informative. Peak height (a1 and a2) and peak area (b1 and b2) of informative alleles were used to calculate percent chimerism. (a1) Graphical representation of calculated vs expected peak heights for informative alleles at different dilutions. (a2) Graphical representation of an average of all six informative markers calculated using peak heights. Even though marker FGA in Figure a1 appears to outlie the others, when plotted as an average of all six markers, concordance between the calculated and the expected peak heights showed minimal deviation from 1 (R 2 = 0.99). (b1) Graphical representation of calculate vs expected peak areas for informative alleles at different dilutions. (b2) Graphical representation of an average of all six informative markers calculated using peak areas. Even though marker FGA in Figure a1 appears to outlie the others, when plotted as an average of all six markers, concordance between the calculated and the expected peak areas showed minimal deviation from 1 (R 2 = 0.99).
amplified alleles originate from the recipient or donor or represent a mixture of both. All donors were blood relatives of the recipients. The number of informative markers ranged from four to eight. The results are shown in Table  3 . In five patients, the donor/recipient profiles were also tested on an AlfExpress instrument (Pharmacia) using an eight STR panel of fluorescent markers (Promega). The results were identical to those obtained with the Profiler kit. Quantitative assessment was derived using informative allele peak areas. The number of informative markers varied between four and eight.
Discussion
We found that automated fluorescent-tagged primer-based PCR of highly polymorphic STRs permits increased scoring accuracy, a higher likelihood of an informative test interpretation, and genotyping efficiency. The quantitative capabilities of the Applied Biosystems 377 Sequencer and GeneScan and Genotype software provide very good precision irrespective of whether quantitative measures were derived from peak areas or peak height of donor and recipient alleles. The latter is clearly illustrated from the simulated chimeric sample experiments (Figures 2 and 3) where the standard curve is directly proportional to the extent of engraftment (proportions of mixed DNA) irrespective of peak areas or peak heights, or which marker was used. Multiplex analysis of 10 markers in the same tube with a fourcolor detection system permits analysis of multiple sets of samples or multiple loci for a single sample on one gel. Chimeric populations created by introducing varying proportions of samples from two unrelated donors, by either mixing aliquots of DNA isolated from whole blood, or by first counting the white blood cells and mixing varying proportions of cells together prior to DNA isolation indicated peak area ratios identical to peak height ratios. The latter corresponded to the proportion of mixed DNA, regardless of the method used to create the mixture.
On an average 50% of the markers were informative with a sensitivity of less than 2.5%. At 1% sensitivity, detection of an allele peak was not always unequivocal and often inconsistent for the markers employed. The more quantitative and enhanced sensitivity afforded by automated fluorescent-tagged primer-based PCR with a power of discrimination Ͼ99.999% for both African-Americans and US caucasians (PE Applied Biosystems, Alameda, CA, USA; Profiler user manual, 13-8) can be critical in providing more accurate interpretation of chimeric states.
Potential problems with 'stutter peaks' are drastically reduced or eliminated by the ABI Profiler kit. In many STR analyses, interpretation and quantification are hampered by 'stutter peaks'. These additional peaks are produced in the PCR reaction by product re-annealing, by properties inherent in some polymerases which add an additional A at the end, and by mobility differences between complementary strands. The Profiler kit uses tetranucleotide repeats that are less prone to stutter peaks. In addition, the use of only one labeled primer of each primer pair allows detection of only one strand for each amplified DNA fragment. The latter eliminates doublets arising from the different mobilities of complimentary strands that are often observed when using gel staining or label incorporation methods. In our study, stutter peaks did not interfere with the analyses.
A laboratory should establish 'normal ranges' for each patient population at different time intervals after transplantation so as to monitor the stability of recipient cells. Time trends are often more useful than test results from any single time point. 9 In summary, automated fluorescent-tagged primer-based PCR of highly polymorphic STRs permits reliable, increased scoring accuracy, a higher likelihood of an informative interpretation, and genotyping efficiency for the evaluation of engraftment status in the stem cell transplantation setting.
